Table 3.
Concerns and dislikes of current treatments for VVA.
| TOP CONCERNS AND DISLIKES REGARDING CURRENTLY AVAILABLE TREATMENTS FOR VULVAR AND VAGINAL ATROPHY | ||
|---|---|---|
| OTC LUBRICANTS OR MOISTURIZERS (n = 1227) | VAGINAL ESTROGEN (n = 409) | NEVER USED OTC LUBRICANTS OR MOISTURIZERS OR VAGINAL ESTROGEN (n = 788) |
| Messiness (43%) | Long-term safety (41%) | Symptoms not bothersome enough (44%) |
| Vagina not restored to natural (39%) | Vagina not restored to natural (36%) | Assumed symptoms would go away (30%) |
| Lack of symptom relief (28%) | Concerns regarding hormone exposure (35%) | Concerns regarding side effects (28%) |
| Loss of sexual spontaneity (23%) | Cost (31%) | Lack of symptom relief (23%) |
| Issues of administration (23%) | Concerns regarding breast cancer (29%) | Issues of administration (21%) |
| Inconvenience (17%) | Risk of side effects (26%) | Inconvenience (17%) |
| Lack of privacy (11%) | Lack of symptom relief (23%) | Concerns regarding hormone exposure (16%) |
| Vaginal discharge (10%) | Issues of administration (21%) | Risk of side effects (13%) |
| Vaginal delivery (9%) | Messiness (19%) | Concerns regarding breast cancer (10%) |
| Cost (8%) | Inconvenience (18%) | Messiness (7%) |